Want to join the conversation?
At the end of FY16, $CSRA's ratio of net debt-to-total capitalization was 92.7%, an increase of 81 percentage points from the end of FY15. The increase in the ratio was mainly the result of the addition of new debt as a result of the spin-off and mergers.
$BABA seems to be on a roll! But increasing its yearly sales outlook from 48% to 54% seems over-expectation from the company's part, doesn't it?
$JNJ down 2% in pre-market trading. Earnings beat expectations, but sales disappointed. Johnson is cautious on its outlook. How it will perform in the future?